Latest Event Updates
According to a new report published by Allied Market Research titled, UK IVF Services Market by End User and Cycle Type: Opportunity Analysis and Industry Forecast, 2014-2022, the UK IVF services market is estimated to reach $685.4 million by 2022, registering a CAGR of 7.7% from 2016 to 2022.
Early Buyers will receive 20% customization on this report.
The UK IVF services market is characterized by important factors such as increase in cases of infertility, delayed marriages, and parenthood decisions. In addition, decrease in birthrate also boost the market growth. For instance, in 2014 total fertility rate decreased to 1.83 per woman from 1.85 in 2013. The IVF services market in the UK is anticipated to experience a continuous growth due to supportive regulatory bodies such as Human Fertilization and Embryo authority (HFEA), which closely regulates the functioning of IVF treatments and research involving human embryos in the UK supplements the market growth. The growth of the market is associated with decrease in birthrate, increase in infertility, and supportive regulations for IVF treatments.
The fertility clinics segment is anticipated to dominate the market during the forecast period in terms of volume and revenue. This is because the fertility clinics provide technologically advanced and wide range of fertility treatments under one roof for patients.
Key Findings of the UK IVF Services Market:
- Based on cycle type, fresh IVF cycles (non-donor) is projected to be one of the fastest growing segment at a CAGR of 8.3% from 2016 to 2022, in terms of revenue
- Based on end users, fertility clinics is projected to be the one of the fastest growing segment at a CAGR of 8.9% from 2016 to 2022, in terms of revenue
- Based on cycle type, fresh IVF cycle (non-donor) is projected to be the one of the fastest growing segment at a CAGR of 7.6% from 2016 to 2022, in terms of volume
- Based on end users, fertility clinics is projected to be the one of the fastest growing segment at a CAGR of 8.2% from 2016 to 2022, in terms of volume
Key players in the UK IVF services market includes companies, hospitals, surgical centers, fertility centers, and clinical research institutes. These includes Lister Fertility Clinics, The Bridge center, and Chelsea and Westminster Hospital.
According to the recent report published by Allied Market Research, titled, Pipeline Monitoring Systems Market by Pipe, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global pipeline monitoring systems market size was valued at $4,514 million in 2016, and is estimated to reach at $7,371 million by 2023, registering a CAGR of 7.5% from 2017 to 2023. North America constituted around 42.6% share in 2016 in the global pipeline monitoring systems market, and is expected to maintain its dominance throughout the analysis period, registering a CAGR of 6.5%.
Access Full Summary at: https://www.alliedmarketresearch.com/pipeline-monitoring-systems-market
The factors that drive the growth of the pipeline monitoring systems market are increased oil & gas leakages, government regulations concerning safety, and higher need to prevent storage tanks from natural disasters. In addition, high investments in pipeline infrastructure acts as an opportunity to the pipeline monitoring systems market growth. However, political instability is expected to impede the market growth. Innovative production for pipeline monitoring fuels the global pipeline monitoring systems market growth. Many oil & gas companies prefer ultrasonic testing technology as it detects small & large leakages, which generated highest revenue in 2016.
Non-metallic pipe is the most commonly used pipe in the pipeline monitoring systems industry as it costs lower than the metallic pipe and requires low maintenance. However, metallic pipes are expected to exhibit the highest growth rate such pipe types are stronger and more fracture resistant than non-metallic pipes. Therefore, several petroleum companies use metallic pipes for better transmission of water and sewage.
The end users of the pipeline monitoring systems industry are petroleum, water & wastewater, and others. The petroleum industry generated the highest revenue in 2016, and is expected to maintain this trend during the forecast period. With the growing focus towards pipeline safety and monitoring in petroleum sector, the industry is expected to grow at the notable rate by 2023.
Asia-Pacific is expected to grow at the highest CAGR of 9.4%, owing to the increased investments in pipeline infrastructure in countries, such as China, Japan, and India among others. However, LAMEA is the second highest growing region due to strong growth in oil & gas sector in the Middle East and Africa, which has further led to expansion of pipeline network.
Do enquiry for sample report at: https://www.alliedmarketresearch.com/request-sample/2314
Key Findings of the Pipeline Monitoring Systems Market:
- LAMEA is projected to be the second highest growing region in the global pipeline monitoring systems market, in terms of revenue, registering a CAGR of 8.7% from 2017 to 2023.
- Smart ball witnessed significant growth in 2016, and is anticipated to grow at the highest CAGR of 9.2%.
- Non-metallic pipe was the highest revenue contributor to the market with 67.0% share in 2016, and is expected to maintain its dominance throughout the forecast period.
- Petroleum industry in the pipeline monitoring systems market generated the highest revenue in 2016, and is expected to grow at a CAGR of 6.1%.
The key pipeline monitoring systems industry players profiled in the report include Orbcomm Inc., Transcanada Company, PSI AG, Pure Technologies, Honeywell International Inc., Perma Pipe Inc., Siemens AG, Huawei Technologies Co. Ltd., BAE Systems, Inc., and Pentair PLC.
Do enquiry before purchasing at: https://www.alliedmarketresearch.com/purchase-enquiry/2314
Increased application of nanocoatings in electronics and automobile industries is expected to offer lucrative opportunities for the global nanocoatings market. Asia-Pacific dominated the market in 2015 due to rise in disposable income resulting in the high standard of living.
Nanocoatings Market Report, published by Allied Market Research, projects that the global market was valued at $3,327 million in 2015, and is expected to reach $13,094 million by 2022, growing at a CAGR of 21.0% during the forecast period. The self-cleaning (bionic & photocatalytic) segment was the largest contributor to the global nanocoatings market in 2015. In the same year, North America held the leading position, and is expected to continue its dominance in the future.
“Early buyers will receive 20% customization on this report.”
Nanocoatings offer various benefits such as protection from whether conditions, abrasion resistance, and UV resistance, thus fueling their adoption globally. Self-cleaning segment (bionic & photocatalytic) generated the highest revenue in 2015, as these type of nanocoatings possess the ability to clean themselves by undergoing chemical changes. They are made up of nanoparticles that show super-hydrophilic and super-hydrophobic surfaces, which offer them the self-cleaning ability.
Request for sample copy of the report at: https://www.alliedmarketresearch.com/request-sample/2064
The electronics segment accounted for the highest revenue in 2015, as electronic components need to be protected from environmental conditions that may reduce their efficiency. These nanocoatings are also used in applications such as the automotive, textile, and construction industries, owing to their anticorrosion, anti-microbial, and easy cleaning properties.
Key Findings of the Nanocoatings Market:
• The electronics application occupied the highest share in 2015, and is expected to grow at a CAGR of 21.0%, in terms of value, during the forecast period.
• North America is the leading consumer of nanocoatings, accounting for approximately more than two-fifths share of the global market, followed by Europe.
• Anticorrosion segment is expected to witness the highest CAGR of 36.4% during the forecast period.
• Automotive & construction segment accounted for one-fourth of the global nanocoatings market in 2015.
• U.S. is the leading market in North American, growing at a CAGR 21.4%.
North America accounted for the largest market share in 2015, whereas Asia-Pacific is projected to grow at the highest CAGR of 23.3% during the forecast period. Utilization of nanocoatings for the prevention of infections due to unhealthy surroundings is expected to increase the demand for nanocoatings from the healthcare industry. Steady growth in the automotive and construction industries in China and India is expected to increase the demand for nanocoatings in the Asian market.
The prominent players profiled in this report include Buhler AG, Nanogate AG, Nanophase Technologies Corporation, Bio-Gate AG, Admat Innovations, Surfix BV, Nanomech Inc., EIKOS Inc., CIMA Nanotech, and Duraseal Coatings Company LLC.
For purchase enquiry of the report, visit at: https://www.alliedmarketresearch.com/purchase-enquiry/2064
Upsurge in demand for smart polymers in numerous applications (owing to its exclusive environmental responsive property and increasing research activities) are the prime drivers of the market. However, high cost associated with the use of smart polymers is projected to hamper the market growth during the forecast period.
Smart Polymers Market Report, published by Allied Market Research, projects that the global market was valued at $1,250 million in 2015, and is estimated to reach $3,070 million by 2022, growing at a CAGR of 12.6% from 2016 to 2022. In 2015, physical stimuli responsive segment held almost half of the share of the total market.
“Early buyers will receive 20% customization on this report.”
Smart polymer is a subject of great interest for institutional and industrial research. Properties of these polymers such as shape, mechanical properties, phase separation, permeability, and electrical properties changes in response to small variation in environmental conditions. These polymers are widely used in biomedical & biotechnology applications such as drug delivery, tissue engineering, and cell culture support. The extensive research and novel qualities of these polymers has shown significant growth in the market, and is expected to provide lucrative opportunity in the near future.
The growth of the global smart polymers market is driven by the rise in need for efficient & economical drug delivery system, innovative use of smart polymers in the automobile industry, and significant reversible phase transition property of smart polymers. Development of smart polymers from renewable feedstock and increase in awareness about smart polymers in future are expected to provide significant growth opportunities to the industry players. However, high R&D cost increases the overall cost of smart polymers, which is anticipated to hamper the market growth during the forecast period.
Click here to get sample copy of this report.
Physical stimuli responsive is the leading segment which are sensitive to environmental factors such as temperature, light, electric field, magnetic field, and mechanical stress, which are widely used as safe polymers in drug delivery and biomaterials.
Shape memory polymer type segment generated the highest revenue in 2015, with almost half of the total market share, followed by self-healing polymer segment. Shape memory polymers retain their original shape at the culmination of the environmental stimulus. These polymers are used in wide range of applications such as surgical fixation, telecommunication, clothing, automotive, and robotics.
Biomedical & biotechnology application segment dominated the global market with more than two-fifths of the global smart polymers share in 2015. Smart polymers are used in multiple biomedical applications such as drug delivery, tissue engineering, bio-separation, biocatalyst, and others.
Key Findings of the Smart Polymers Market:
• In 2015, North America dominated the global market with around one-third of the share, in terms of revenue.
• Chemical stimuli responsive segment is estimated to display the highest growth rate, in terms of revenue, registering a CAGR of 12.8% from 2016 to 2022.
• Asia-Pacific is projected to grow at a highest CAGR of 13.4%, in terms of volume.
• Textile application segment is projected to grow at a highest CAGR of 13.0%, in terms of revenue.
• Self-healing type segment shows the highest growth rate, in terms of revenue, registering a CAGR of 12.9%.
In 2015, North America was the leading region, owing to the increase in research activities and growth in technological advancement for biomedical application. Furthermore, Asia-Pacific is projected to show the highest CAGR of 12.8%, followed by Europe at a CAGR of 12.7% from 2016 to 2022.
The major companies profiled in the report include Covestro AG, BASF SE, Saudi Arabia Basic Industries Corporation (SABIC), Akzonobel, Nippon Shokubai, FMC Corporation, Autonomic Materials Inc., Advanced Polymer Materials Inc., Lubrizol Corporation, and Nexgenia Corporation.
For purchase enquiry of the report, visit at: https://www.alliedmarketresearch.com/purchase-enquiry/2154
According to a new report published by Allied Market Research, titled, “Edible Packaging Market by Material type and End user: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the edible packaging market was valued at $697 million in 2016, and is projected to reach at $1,097 million by 2023, growing at a CAGR of 6.81 % from 2017 to 2023. Europe is expected to be the leading contributor to the global edible packaging market, followed by North America and Asia-Pacific.
Increase in consumption of processed food & beverages, reduction in packaging wastage, rise in hygiene concerns among people and increase in shelf life of products, growth in disposable income of consumers, and rise in standard of living encourages the adoption of edible packaging products in the industry and thus drive the edible packaging market growth. In addition, this eco-friendly packaging technique helps preserve the environment as the products are renewable as well as edible and safe for human consumption thereby reducing plastic packaging waste and fueling the edible packaging market growth.
However, the higher cost of edible packaging materials in comparison with the synthetic materials and high regulatory requirements is expected to hamper the edible packaging market growth. Various advancements in technology such as introduction of nanotechnology in packaging as well as the addition of healthy proteins in the edible food packaging is expected to provide numerous opportunities in the edible packaging market.
In 2016, the lipid-based edible packaging segment accounted for the maximum revenue share in the overall edible packaging industry as they are excellent barrier of oxygen and water vapor and prevents the food from contamination. Protein-based films are expected to grow at a fastest CAGR of 7.5% in the edible packaging industry owing to the value-added benefits of proteins to the body such as high immunity and proper functioning of human body as well as improvement in energy levels in humans. Protein films are made up of corn zein, gluten, and caseins, which are considered safe for human consumption.
Moreover, the food & beverages segment held the highest market share in 2016 for of around 72% in the end user segment in the global edible packaging market.
Moreover, the composite films are expected to grow at a CAGR of 7.2% during the forecast period. The demand for polysaccharides is expected to increase as they help preserve the quality of the food and improve the shelf life of the products; they are widely used in the pharmaceutical industry.
View full report research @ https://goo.gl/AjnwDm
Europe accounted for the major share of the global edible packaging market in 2016 owing to the growth of food & beverages segment and stringent regulations regarding the same. North America is expected to generate the maximum revenue during the forecast period. Asia-Pacific is estimated to grow at the highest rate in the global edible packaging market due to rise in preference of hygienic packaging and the growth of pharmaceutical industry in this region.
Key Findings of the Edible Packaging Market:
- In 2016, the lipids segment accounted for the maximum revenue, and is projected to grow at a notable CAGR of 6.1% during the forecast period.
- The pharmaceuticals segment accounted for 27.56% in the global edible packaging market.
- The U.S. is the major shareholder in the North America edible packaging market, accounting for more than 42% share in 2016.
The key players profiled in the edible packaging market includes WikiCell Designs Inc, MonoSol LLC, Tate & Lyle Plc, JRF Technology LLC, Safetraces, Inc., BluWrap, Skipping Rocks Lab, Tipa Corp, Watson, Inc., and Devro plc. Market players have adopted various strategies, such as product launch, collaboration & partnership and acquisition, to expand their foothold in the market.
According to a new report published by Allied Market Research, titled, Precision Medicine Market by Technology, Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global precision medicine market accounted for $3,516 million in 2016, and is estimated to reach at $7,746 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. North America was the highest contributor in the precision medicine market in 2016; however, Asia-Pacific is anticipated to witness a highest growth rate throughout the forecast period.
Access Full Summary at: https://www.alliedmarketresearch.com/precision-medicine-market
Precision medicine is novel approach toward disease treatment in healthcare, medications are customized based on patients personalized healthcare needs such as, influence of genes & surrounding environment on patients health and result of various tests carried out on various levels. Follow-up on tests and treatment can be planned based on response of the patients toward treatment, which reduces side effects of drug and multiple administration of medications.
The precision medicine market is expected to grow at a productive rate the during forecast period. Surge in global incidence of cancer and increase in aging population susceptible to diseases are expected to boost the demand of precision medicines. Government initiatives & grants and private companies investing in R&D of precision medicines boost the market growth. However, strict regulation set by governments and risk associated with sharing genetic data of patients impedes the growth of precision medicine market.
Drug discovery generated the highest revenue in 2016, and is anticipated to continue this trend in the future. The requirement of quality drugs and versatile therapies for treatment is expected to boost the growth of this segment. Gene sequencing grows at a surprising rate and is expected to continue to grow during the forecast period.
Do enquiry for sample report at: https://www.alliedmarketresearch.com/request-sample/2311
North America holds the highest market share in 2016 owing to high prevalence rate of cancer and modern healthcare facilities. Moreover, adoption of experimental medicines and growth in awareness about precision medicines is expected to boost the North America market. However, Asia-pacific region is expected to grow at the highest CAGR during the forecast period considering, swift industrialization in the area, increase in disposable income, and upsurge in government initiatives to modernize healthcare infrastructure.
Key Findings of the Precision Medicine Market:
- The sequencing by synthesis segment is projected to grow at the highest CAGR during the analysis period.
- Consumables segment generated the highest revenue and is expected to continue its dominance in future.
- North America dominated the market and is projected to grow at a CAGR of 11.0%.
- China is expected to grow at the highest CAGR of 16.8% in Asia-Pacific.
- The epigenomics segment is anticipated to grow at the highest CAGR of 14.1% during the forecast period.
The key companies profiled in the report include Roche Holding AG, Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Quest Diagnostics, Laboratory Corporation of America Holdings, Novartis AG, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly & Company.
Do enquiry before purchasing at: https://www.alliedmarketresearch.com/purchase-enquiry/2311